N- and O-glycome analysis of serum and urine from bladder cancer patients using a high-throughput glycoblotting method

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Glycomics & Lipidomics

• Publication date

  2013-11-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4172/2153-0637.1000108
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum glycan as a prognostic marker in patients with advanced hepatocellular carcinoma treated with sorafenib

  2014cited by this paper
• Serum N-glycan alteration associated with renal cell carcinoma detected by high throughput glycan analysis.

  2014cited by this paper
• Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis

  2013cited by this paper
• Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer

  2013cited by this paper
• N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.

  2012cited by this paper
• The Tn Antigen—Structural Simplicity and Biological Complexity

  2011cited by this paper
• Toward automated glycan analysis.

  2011cited by this paper
• Comparison of the sensitivity and specificity of urine cytology, urinary nuclear matrix protein-22 and multitarget fluorescence in situ hybridization assay in the detection of bladder cancer

  2011cited by this paper
• Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia.

  2011cited by this paper
• Glycoblotting-assisted O-glycomics: ammonium carbamate allows for highly efficient o-glycan release from glycoproteins.

  2010cited by this paper
• Over-expression of ST3Gal-I promotes mammary tumorigenesis

  2010cited by this paper
• Diagnostic value of the hemopexin N-glycan profile in hepatocellular carcinoma patients.

  2010influential reference
• High expression of alpha 2, 3-linked sialic acid residues is associated with the metastatic potential of human gastric cancer.

  2009cited by this paper
• Threshold in Stage-specific Embryonic Glycotypes Uncovered by a Full Portrait of Dynamic N-Glycan Expression during Cell Differentiation*

  2009cited by this paper
• ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines

  2009cited by this paper
• Loss of expression of N‐acetylglucosaminyltransferase Va results in altered gene expression of glycosyltransferases and galectins

  2008cited by this paper
• Comprehensive approach to structural and functional glycomics based on chemoselective glycoblotting and sequential tag conversion.

  2008cited by this paper
• BlotGlycoABC™, an Integrated Glycoblotting Technique for Rapid and Large Scale Clinical Glycomics *S

  2008cited by this paper
• The Metastatic Stage-dependent Mucosal Expression of Sialic Acid is a Potential Marker for Targeting Colon Cancer with Cationic Polymers

  2008cited by this paper
• Focused glycomic analysis of the N‐linked glycan biosynthetic pathway in ovarian cancer

  2008cited by this paper
• Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation.

  2007cited by this paper
• Rapid and simple solid-phase esterification of sialic acid residues for quantitative glycomics by mass spectrometry.

  2007cited by this paper
• Quantitative Glycomics of Human Whole Serum Glycoproteins Based on the Standardized Protocol for Liberating N-Glycans *S

  2007cited by this paper
• Complex N-glycan and metabolic control in tumor cells.

  2007cited by this paper
• Fucosylated haptoglobin is a novel marker for pancreatic cancer: A detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation

  2006cited by this paper
• Predictive value of N-acetylglucosaminyltransferase-V for superficial bladder cancer recurrence.

  2006cited by this paper
• Mucin‐type O‐glycans in human colon and breast cancer: glycodynamics and functions

  2006cited by this paper
• High-throughput protein glycomics: combined use of chemoselective glycoblotting and MALDI-TOF/TOF mass spectrometry.

  2004cited by this paper
• The BTA stat test is nonspecific for hematuria: an experimental hematuria model.

  2002cited by this paper
• Natural killer cells attack tumor cells expressing high levels of sialyl Lewis x oligosaccharides

  2002cited by this paper
• Glycosylation defining cancer malignancy: New wine in an old bottle

  2002cited by this paper
• Sialyltransferases in cancer

  2001cited by this paper
• [A case of transitional cell carcinoma of the urinary bladder with high serum level of CEA and CA19-9].

  2001cited by this paper
• AFP-L3: a new generation of tumor marker for hepatocellular carcinoma.

  2001influential reference
• Screening and monitoring for bladder cancer: refining the use of NMP22.

  2001cited by this paper
• O-Linked Glycosylation in the Mammary Gland: Changes that Occur During Malignancy

  2001cited by this paper
• Glycoprotein glycosylation and cancer progression.

  1999cited by this paper
• Pathways of O-glycan biosynthesis in cancer cells.

  1999cited by this paper
• Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA stat.

  1999cited by this paper
• On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database.

  1999cited by this paper
• Comparison of screening methods in the detection of bladder cancer.

  1999cited by this paper
• Characterisation of peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase A and its N-glycans.

  1998cited by this paper
• Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoprotein.

  1998influential reference
• Gene expression of α1‐6 fucosyltransferase in human hepatoma tissues: A possible implication for increased fucosylation of α‐fetoprotein

  1998cited by this paper
• Expression of the endogenous galactose‐binding protein galectin‐3 correlates with the malignant potential of tumors in the central nervous system

  1997cited by this paper
• Histopathological study of microspherophakia in the Weill-Marchesani syndrome.

  1995cited by this paper
• Fucosylation Index of α‐Fetoprotein, a Possible Aid in the Early Recognition of Hepatocellular Carcinoma in Patients with Cirrhosis

  1993cited by this paper
• Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases.

  1989cited by this paper
• Recognition of oligosaccharide substrates by N-acetyl-glucosaminyltransferase-V.

  1988cited by this paper
• Sialic acid as a marker for differentiation between benign and malignant intracranial tumors.

  1988cited by this paper
• Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis.

  1987cited by this paper

• Altered Glycosylation in Progression and Management of Bladder Cancer

  2023cites this paper
• Machine learning diagnosis by immunoglobulin N‐glycan signatures for precision diagnosis of urological diseases

  2022cites this paper
• N‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas

  2021cites this paper
• Narrative review of urinary glycan biomarkers in prostate cancer

  2020influential citation
• Highly Sensitive O-Glycan Profiling for Human Serum Proteins Reveals Gender-Dependent Changes in Colorectal Cancer Patients.

  2019cites this paper
• Serum N-glycan profiling can predict biopsy-proven graft rejection after living kidney transplantation

  2019cites this paper
• Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks

  2019cites this paper
• Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas

  2017cites this paper
• Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant

  2017cites this paper
• Clinical implications of serum N‐glycan profiling as a diagnostic and prognostic biomarker in germ‐cell tumors

  2017cites this paper
• Methods for the absolute quantification of N-glycan biomarkers.

  2016cites this paper
• Significance of Serum N-glycan Profiling as a Diagnostic Biomarker in Urothelial Carcinoma.

  2016influential citation
• Use of Aleuria alantia Lectin Affinity Chromatography to Enrich Candidate Biomarkers from the Urine of Patients with Bladder Cancer

  2015cites this paper
• A comprehensive glycome profiling of Huntington's disease transgenic mice.

  2015cites this paper
• Quantitative glycome analysis of N-glycan patterns in bladder cancer vs normal bladder cells using an integrated strategy.

  2015cites this paper
• Serum tri‐ and tetra‐antennary N‐glycan is a potential predictive biomarker for castration‐resistant prostate cancer

  2014cites this paper